TY - JOUR
T1 - Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse
AU - Machtay, Mitchell
AU - Scherpereel, Arnaud
AU - Santiago, José
AU - Lee, James
AU - McDonough, Jim
AU - Kinniry, Paul
AU - Arguiri, Evguenia
AU - Shuvaev, Vladimir V.
AU - Sun, Jing
AU - Cengel, Keith
AU - Solomides, Charalambos C.
AU - Christofidou-Solomidou, Melpo
N1 - Funding Information:
Funded in part by American Cancer Society IRG #78-002-23 (Machtay); National American Lung Association #RG-087-N, National Institute of Health NIH-1R21CA-(118111-01) and University of Pennsylvania Research Foundation (Christofidou-Solomidou).
PY - 2006/11
Y1 - 2006/11
N2 - Purpose: Since oxidative injury is implicated in radiation-induced tissue damage to the lung, we studied systemically administered polyethylene glycol (PEGylated) antioxidant enzymes (AOEs) as pulmonary radioprotectors in mice. Methods and materials: C57/bl6 Mice received 13.5 Gy single-dose irradiation to the thorax. One cohort also received 100 μg of a 1:1 mixture of PEG-AOEs {PEG-catalase and PEG-superoxide dismutase (SOD)} intravenously, pre-irradiation and subgroups were evaluated at variable time-points for inflammation and fibrosis. Potential for AOE tumor protection was studied by thoracic irradiation of mice with Lewis lung carcinoma. Results: At 48 h post-irradiation, control irradiated mice had marked elevations of tissue p21, Bax and TGF-β1 in lungs, not seen in irradiated, PEG-AOE-treated mice. TUNEL staining of lung sections was performed at just one time-point (24 h post-irradiation) and revealed a decrease in apoptotic cells with AOE treatment. At four months post-irradiation, these mice had significantly increased pulmonary fibrosis as measured by hydroxyproline content. Mice treated with PEG-AOE prior to irradiation had 4-month hydroxyproline levels that were similar to that of unirradiated controls (p = 0.28). This corresponded to less pulmonary fibrosis as visualized histologically when compared with mice irradiated without AOEs. PEG-AOEs did not prevent post-irradiation pulmonary inflammation or lung cancer response to irradiation. Conclusions: A mixture of PEG-SOD and PEG-CAT successfully diminished radiation pulmonary fibrosis in mice. There was also a corresponding effect on several early biomarkers of lung injury and decreased apoptosis. There were no significant effects on acute pneumonitis or tumor protection.
AB - Purpose: Since oxidative injury is implicated in radiation-induced tissue damage to the lung, we studied systemically administered polyethylene glycol (PEGylated) antioxidant enzymes (AOEs) as pulmonary radioprotectors in mice. Methods and materials: C57/bl6 Mice received 13.5 Gy single-dose irradiation to the thorax. One cohort also received 100 μg of a 1:1 mixture of PEG-AOEs {PEG-catalase and PEG-superoxide dismutase (SOD)} intravenously, pre-irradiation and subgroups were evaluated at variable time-points for inflammation and fibrosis. Potential for AOE tumor protection was studied by thoracic irradiation of mice with Lewis lung carcinoma. Results: At 48 h post-irradiation, control irradiated mice had marked elevations of tissue p21, Bax and TGF-β1 in lungs, not seen in irradiated, PEG-AOE-treated mice. TUNEL staining of lung sections was performed at just one time-point (24 h post-irradiation) and revealed a decrease in apoptotic cells with AOE treatment. At four months post-irradiation, these mice had significantly increased pulmonary fibrosis as measured by hydroxyproline content. Mice treated with PEG-AOE prior to irradiation had 4-month hydroxyproline levels that were similar to that of unirradiated controls (p = 0.28). This corresponded to less pulmonary fibrosis as visualized histologically when compared with mice irradiated without AOEs. PEG-AOEs did not prevent post-irradiation pulmonary inflammation or lung cancer response to irradiation. Conclusions: A mixture of PEG-SOD and PEG-CAT successfully diminished radiation pulmonary fibrosis in mice. There was also a corresponding effect on several early biomarkers of lung injury and decreased apoptosis. There were no significant effects on acute pneumonitis or tumor protection.
UR - http://www.scopus.com/inward/record.url?scp=33751214559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751214559&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2006.09.013
DO - 10.1016/j.radonc.2006.09.013
M3 - Article
C2 - 17069914
AN - SCOPUS:33751214559
SN - 0167-8140
VL - 81
SP - 196
EP - 205
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 2
ER -